Cefprozil

Cefprozil

Clinical data
Pregnancy category	Category-B
Routes of administration	ORAL
ATC code	J01DC10 (WHO)
Pharmacokinetic data
Bioavailability	95%
Protein binding	36%
Elimination half-life	1.3 hours
Identifiers
IUPAC name 8-[2-amino-2-(4-hydroxyphenyl)-acetyl] amino-7-oxo-4-prop-1-enyl-2-thia-6- azabicyclo [ 4.2.0]oct-4-ene-5-carboxylic acid
CAS Number	92665-29-7
PubChem CID	5281006
DrugBank	APRD00461
ChemSpider	4941253
CompTox Dashboard (EPA)	DTXSID10873545
Chemical and physical data
Formula	C18H19N3O5S
Molar mass	389.427 g/mol g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C2N1/C(=C(/C=C/C)CS[C@@H]1[C@@H]2NC(=O)[C@@H](c3ccc(O)cc3)N)C(=O)O.O
(verify)

Cefprozil, sometimes spelled cefproxil and sold under the brand name Cefzil, is a second-generationcephalosporin type antibiotic. In Europe, it is sold by the name Procef. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.

Although there is a widely quoted cross-allergy risk of 10% between cephalosporins and penicillin, an article in the Journal of Family Practice (February 2006) has shown no increased risk for cross-allergy for cefprozil and several other 2nd generation or later cephalosporins.

External links

• Information about Cefprozil